- Home
- RXRX vs SRRK Comparison
RXRX vs SRRK Comparison
Compare RXRX & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXRX
- SRRK
- Stock Information
- Founded
- RXRX 2013
- SRRK 2012
- Country
- RXRX United States
- SRRK United States
- Employees
- RXRX N/A
- SRRK N/A
- Industry
- RXRX Biotechnology: Pharmaceutical Preparations
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RXRX Health Care
- SRRK Health Care
- Exchange
- RXRX Nasdaq
- SRRK Nasdaq
- Market Cap
- RXRX 2.6B
- SRRK 3.1B
- IPO Year
- RXRX 2021
- SRRK 2018
- Fundamental
- Price
- RXRX $4.46
- SRRK $31.32
- Analyst Decision
- RXRX Buy
- SRRK Strong Buy
- Analyst Count
- RXRX 5
- SRRK 6
- Target Price
- RXRX $7.60
- SRRK $42.17
- AVG Volume (30 Days)
- RXRX 23.1M
- SRRK 1.4M
- Earning Date
- RXRX 05-05-2025
- SRRK 05-14-2025
- Dividend Yield
- RXRX N/A
- SRRK N/A
- EPS Growth
- RXRX N/A
- SRRK N/A
- EPS
- RXRX N/A
- SRRK N/A
- Revenue
- RXRX $59,790,000.00
- SRRK N/A
- Revenue This Year
- RXRX $57.30
- SRRK N/A
- Revenue Next Year
- RXRX $51.53
- SRRK $601.05
- P/E Ratio
- RXRX N/A
- SRRK N/A
- Revenue Growth
- RXRX 29.32
- SRRK N/A
- 52 Week Low
- RXRX $3.79
- SRRK $6.76
- 52 Week High
- RXRX $12.36
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- RXRX 39.10
- SRRK 49.35
- Support Level
- RXRX $4.11
- SRRK $28.76
- Resistance Level
- RXRX $5.90
- SRRK $33.48
- Average True Range (ATR)
- RXRX 0.38
- SRRK 1.66
- MACD
- RXRX -0.10
- SRRK -0.00
- Stochastic Oscillator
- RXRX 20.25
- SRRK 43.66
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.